Cel-Sci's Targets Stay on Track 20 comments
an article to
-
Font Size:
-
Print
- TweetThis
Last week I had the opportunity to visit Cel Sci's (CVM) new, state of the art Multikine production facility near Baltimore, MD. During the visit, I was given a tour of the interior by Dr. Eyal Talor and Mr. W. Brooke Jones of Cel Sci Corp. Upon the completion of my visit, I came to the conclusion that the company's previously announced time frame for validation of the facility (of fourth quarter, 2009) was on target.
The tour was arranged on the efforts of BioMedReports and Cel Sci and a complete report from my tour inside the facility can be read on the BioMedReports web site.
During the tour I saw nothing that would incline me to alter my stance of playing CVM as a 'buy the dips' stock; and I continue to have confidence in the fact that news regarding the commencement of the long-awaiting Multikine Phase III trial is not too far away.
Aside from the pending Multikine trial, any news regarding the L.E.A.P.S. swine flu treatment could also serve as a price mover for CVM.
I'll continue to accumulate CVM for the long term.
Disclosure: VFC is long CVM.
Related Articles
|
-
The Seeking Alpha 100
See allThe top 100 stock
market authors
selected for publication
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
David Fry
-
2
TraderMark
-
3
Don Dion
-
4
Cliff Wachtel
-
5
Mike Havrilla
Top Instabloggers » -
1
-
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
One has to wonder why a supposedly legitimate company would seek out an amateur and admittedly "small time investor" blogger to tour its facility and issue a "report." That in itself raises more questions than answers about the legitimacy of both parties. But, let's walk through this "report", shall we?
- "Multikine is the company's flagship immunotherapeutic head and neck cancer treatment and is the first immunotherapeutic agent being developed as a first-line standard of care cancer treatment."
Not true.
- "Multikine, already deemed safe and effective in a Phase II trial"
PII trials (esp. uncontrolled ones) cannot "deem" anything as safe or effective, only a fully controlled; PIII registrational trial can do that.
- "so far as to question the genuinity of the company"
No such word as "genuinity".
- "Hosting my media credentialed tour"
What the heck does that mean?
- "As the tour got underway, Dr. Talor and Mr. Jones led me through the hallways, where I observed many Cel-Sci employees hard at work putting the finishing touches on what I could only imagine was a very long and consuming process of validation."
Wow, Gee whiz, look at them fancy beakers over there! Good grief, could it be any more obvious this person has no idea of what they are looking at and are not qualified in the least to make such a "report"?
- "Many areas were deemed either too 'classified' or too 'clean' for the purpose of my visit, but the inner core of the facility was most certainly an impressive maze of rooms dominated by strict standards of cleanliness and air purity. Additionally, the vigorous and measured movement-of-personnel protocol within the 'clean' areas was an indication to me that the facility is just about ready for action."
This is laughable. So, there are areas too "clean" for filthy fake reporters apparently!
"Measured movement of personnel" has to be my favorite. Does that mean they carry pedometers that count steps or what? If you couldn’t see the "clean" areas, than how do you know that the movement was "measured" and further, how could that possibly mean its "ready for action"? You have no clue what you are writing about. Did you just make this crap up? Or do you have an elementary school age child who wrote this for you? This is so bad it made me guffaw so much so that I feared for a moment I would pass out.
- "Quite possibly the most impressive area of the facility was an area that I couldn't see . . ."
Oh my sides! Stop it, you have to be kidding! "Yes, my Vinny, behind that closed door which is too "classified" to show you is the really impressive stuff.” 'Really?! WOW!"
- "In my opinion, the cold fill capability and technology will eventually pay for itself, in terms of product saved and inbound contract revenue."
Aaaand, you know this how?
- "Also worth noting from the tour is the amount of free space available for expansion. The company has made no secret of the extra expansion space, some of which is now being used a warehouse, but all of the extra space will without a doubt be needed if Multikine proves successful in the upcoming Phase III trial."
Oh my sides! So, let me see if I have this right. You are reporting on "free space" as a desirable attribute? (“Of course, you are “certain” that it will be needed in the future”! Even though, I find it hard to understand how it is "free" if it’s being used as a warehouse.)
- "a fully validated production plant is within reach"
Do you have ANY idea as to what goes into a facility validation? By the way, what exactly is your background, career and academically speaking?
This is so hilariously bad writing and pseudo reporting by an obviously unqualified person that I would be fearful that it may actually defeat its purpose, which is obviously to pump the stock.
On Oct 27 07:41 AM BSbuster wrote:
> Sorry, my post got truncated. Here is the complete version:
>
> One has to wonder why a supposedly legitimate company would seek
> out an amateur and admittedly "small time investor" blogger to tour
> its facility and issue a "report." That in itself raises more questions
> than answers about the legitimacy of both parties. But, let
But Vinny - seriously. Surely you still have enough of a lingering conscious to know that you can't pump investigation phase CANCER TREATMENTS as sure things. There is just too much history on the subject for you not to know better. To use terms such as "save millions of lives" is pretty disgusting - especially when you know the history of this treatment.
Please - enough with the rhetoric and give investors some balance.
They're bringing out the whole team to bash you.
Must be because they're upset that Adam F. didn't get a tour and a "small time investor" did. And, their sentence by sentence take down of your article has some really weak, desperate "BS" points in it.
Keep writing Vinny, and ignore those that are bashing out of the fear that we are well into the 4th quarter of 2009 and their "job" might be over soon. One would ask why they bother to constantly appear and comment about a stock they think amounts to nothing?
What stocks would you recommend these days?
Thanks
OMG BSbuster why didn't you say so before, it's clear he only wishes to bash anything that fouls his buying cheeeep shares and trading for a profit. Do you think your negative posts will go away when you bash it down and load up on CVM?
No, it's clear that you KNOW nothing can stop CVM from skyrocketing on it's OWN GOOD NEWS in the future so you bash and buy fully aware of the return to $2+ PPS in the near future.
Nice to know BSbuster's motives isn't it. Good question User 476730.
Keep it real BSbuster.
BTW BSbuster, I haven't decided if I'll bash your post line by line yet, oh yeah, I just did.
So far, the only things this company has been VERY good at is producing copious press releases.
Oct 28
CVM what
Down 15% despite the "report" by the intrepid reporter Vinny "the really impressive part was the part I couldn't see" Cassano?
That's too rich!
Down another 20% today? (And AGEN, the other "billion dollar" company down another 10%, both cut in half since this clown's original pumps!)
Attention readers: I think its obvious why one shouldn't rely on an amateur for stock advice. This person has ZERO clue what he writes about.
His opinion is just that, an opinion, no better than the thousands of opinions you can read everyday on yahoo or other message boards.